Pharmaceutical Preparations · DE · CIK 1979414
Developing novel drugs and delivery methods for aggressive brain cancers
Comparable business profile · signals at a glance
In the 90 days to Nov 24, 2025: 2 insiders bought $192K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 24, 2025 | Heshmatpour Amir FPresident | Buy | 6,000 | $6.51 | $39K |
| Nov 21, 2025 | Heshmatpour Amir FPresident | Buy | 20,000 | $5.98 | $120K |
| Nov 21, 2025 | Heshmatpour Amir FPresident | Buy | 4,000 | $6.50 | $26K |
| Nov 20, 2025 | Neman-Ebrahim YoushaChief Clinical Officer | Buy | 1,100 | $6.69 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.